Teva Bids for BioXcel’s BXCL501 in Potential At-Home Agitation Treatment Deal
Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 24, 2026 United Therapeutics Corporation announced that the U.S....
Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...
ELK GROVE VILLAGE, Illinois, Aug 28, 2026 Orsini announced that it will serve as a specialty pharmacy partner for...
NANJING, China, Aug 28, 2026 InxMed Co., Ltd. announced the publication in The Lancet Oncology of clinical results evaluating...
INDIANAPOLIS, U.S., Aug 28, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has...
SOPHIA ANTIPOLIS, FRANCE, Aug 27, 2026 Nicox SA announced that the U.S. Food and Drug Administration (FDA) has accepted...
MIAMI, August 7, 2026 NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has completed the first-cycle...
MUMBAI, India, and NAPLES, Fla., July 28, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA) approval...
PITTSBURGH, July 29, 2026 Viatris Inc. has received U.S. Food and Drug Administration (FDA) approval for Gwyn Lo™ (norelgestromin...
